Australian Deprescribing Network
  • Home
  • About Us
    • Who are we?
    • ADeN Committees
    • Contact Us
    • FAQ’s
  • Research
    • Research highlights
    • Research tools
    • Helpful links
  • Resources
    • What is deprescribing?
    • Resources for the public
    • Guidelines
    • Resources for healthcare professionals
    • Communication
    • Reports and policy documents
    • Research highlights
    • Helpful links
  • Events
    • Upcoming Annual Meeting
    • Past Annual Meetings
    • Journal Club & Webinars
  • For consumers
    • What is deprescribing?
    • Resources for the public
    • Case studies
    • FAQ’s
    • Helpful links
  • Contact Us
Select Page

GP preferences for discussing statin deprescribing: a discrete choice experiment

Date: 2021, Original research, Research

Date: 2021

Thompson, Wade, et al. “GP preferences for discussing statin deprescribing: a discrete choice experiment.” Family Practice (2021).

Link: https://doi.org/10.1093/fampra/cmab075

Leveraging implementation science to increase the translation of deprescribing evidence into practice

Commentary, Date: 2021, Research

Date: 2021

Citation: Ailabouni, Nagham J., et al. “Leveraging implementation science to increase the translation of deprescribing evidence into practice.” Research in Social and Administrative Pharmacy (2021).

Link: https://doi.org/10.1016/j.sapharm.2021.05.018

Appropriate deprescribing in older people: a challenging necessity Commentary to accompany themed collection on deprescribing

Commentary, Date: 2021, Research

Date: 2021

Citation: van der Velde, Nathalie, and Jatinder S. Minhas. “Appropriate deprescribing in older people: a challenging necessity Commentary to accompany themed collection on deprescribing.” Age and Ageing (2021).

Link: https://doi.org/10.1093/ageing/afab142

Unexpected Findings During Double-blind Discontinuation of Acetylcholinesterase Inhibitor Medications

Date: 2021, Original research, Research

Date: 2021

Citation: Moo, Lauren R., et al. “Unexpected Findings During Double-blind Discontinuation of Acetylcholinesterase Inhibitor Medications.” Clinical Therapeutics (2021).

Link: https://doi.org/10.1016/j.clinthera.2021.05.010

Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data

Commentary, Date: 2021, Research

Date: 2021

Citation: Moriarty, Frank, Wade Thompson, and Fiona Boland. “Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data.” Research in Social and Administrative Pharmacy (2021).

Link: https://doi.org/10.1016/j.sapharm.2021.05.007

Deprescribing in older patients by early-career general practitioners: Prevalence and associations

Australian research, Date: 2021, Original research, Research

Date: 2021

Citation: Magin, Parker, et al. “Deprescribing in older patients by early‐career general practitioners: prevalence and associations.” International journal of clinical practice (2021): e14325.

Link: https://doi.org/10.1111/ijcp.14325

« Older Entries

View research by date

2021

2020

2015-2019

View research by category

Original research

Review

Other research

Commentary

Australian research

Designed by Elegant Themes | Powered by WordPress